Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Colorectal Neoplasms × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphoma 1 Hematologic Diseases 1 Endometrial Neoplasms 1 Burkitt Lymphoma 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cetuximab 5 Bevacizumab 4 pembrolizumab 3 Leucovorin 3 Irinotecan 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 trastuzumab deruxtecan 2 encorafenib 2 Oxaliplatin 2 HMPL-013 2 tucatinib 1 sotorasib 1 regorafenib 1 pralsetinib 1 larotrectinib 1 entrectinib 1 binimetinib 1 adagrasib 1 Trastuzumab 1 Panitumumab 1 Nivolumab 1 Levoleucovorin 1 Ipilimumab 1 IFL protocol 1 Capecitabine 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡